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Thalassemia can lead to severe transfusion-dependent anemia, and it is the most common genetic disorder in Malaysia. This paper
aims to determine the prevalence of thalassemia in the Kadazandusuns, the largest indigenous group in Sabah, East Malaysia. α-
and β-thalassemia were confirmed in 33.6% and 12.8%, of the individuals studied respectively. The high prevalence of α- and
β-thalassemia in the Kadazandusuns indicates that thalassemia screening, genetic counseling, and prenatal diagnosis should be
included as part of their healthcare system. This preliminary paper serves as a baseline for further investigations into the health
and genetic defects of the major indigenous population in Sabah, East Malaysia.
1. Introduction
Malaysia has a multiracial population of 28.3 million,
consisting of 65.1% Malays and other Bumiputera groups:
26% Chinese, 7.7% Indians, and 1.2% of other ethnic groups
(Population and Housing Census, 2000). The “Orang Asli”
or the indigenous population in Malaysia are descendents
of the Austronesian people and they form only 0.6% of
the total population [1]. In West Malaysia, they have been
oﬃcially classified into three main categories—Proto-Malay
(Aboriginal-Malay), Negrito and, Senoi [1]. East Malaysia
has the largest number of indigenous groups which make
up to 60% of Sabah’s and 50% of Sarawak’s population.
The indigenous groups have mainly lived as agricultural and
fishing communities, but many have now integrated into
urban communities and hold important administrative and
academic positions.
The thalassemias are autosomal recessive disorders which
result in reduced production of one or more of the subunits
of hemoglobin. Thalassemia is a public health problem in
Malaysia and about 4.5% of the Malays and Chinese are
β-thalassemia carriers [2]. Beta-thalassemia major produces
severe anemia that requires life-long blood transfusions for
survival. The molecular defects producing β-thalassemia
are heterogeneous, and each ethnic group possesses its
own specific set of mutations [3, 4]. Alpha-thalassemia
has also been reported and the fatal condition, Hb Bart’s
hydrops fetalis, is present mainly in the Malaysian Chinese.
The Malays possess the single α-globin gene deletion that
produces an asymptomatic disorder [5]. Thalassemia has
rarely been observed in the Malaysian Indians who are
migrants mainly from Southern India.
Although thalassemia is the most common genetic dis-
order in Malaysia, there is very little information regarding
the presence of thalassemia in the indigenous population.
A previous study showed that the Filipino β-thalassemia
deletion which involves deletion of the entire β-globin gene
was the only mutation in 20 β-thalassemia major families
from the indigenous communities in Sabah, East Malaysia
[6]. Detailed molecular characterization of mutations that
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cause thalassemia in the Malaysian indigenous populations
is limited, as studies have focused mainly on the major
ethnic groups—Malays, Chinese and Indians. The aim of
this molecular study is to detect the prevalence and types
of α- and β-thalassemia in the Kadazandusuns, the largest
indigenous group in Sabah. Information on the prevalence
and spectrum of thalassemia defects will allow for eﬀective
genetic counseling and prenatal diagnosis of thalassemia in
the Kadazandusuns in Sabah.
2. Materials and Methods
A total of 125 blood samples were obtained with informed
consent from unrelated Kadazandusuns in Sabah in 2008.
Genomic DNA was obtained using conventional phenol-
chloroform extraction. Routine hematology analysis includ-
ing blood films for morphology was not done on the
blood samples as they were collected from the interior and
only reached the laboratory within 7 to 10 days of sample
collection. In a recent study, we demonstrated that there
was a progressive rise of the MCV from day 1 of storage
[7]. High performance liquid chromatography (HPLC) to
quantify hemoglobin subtypes in the blood samples for the
presumptive diagnosis of thalassemia was also not possible
as HPLC has to be carried out within 7 days of collection of
blood samples stored at 4◦C.
2.1. DNA Amplification of the α-Globin Gene. Deletional
α-thalassemia-Southeast Asian deletion (--SEA); rightward
−α3.7 and leftward −α4.2 deletions were confirmed using
a modified multiplex PCR [8]. The Filipino (--FIL) and
Thai (--THAI) α-thalassemia deletions were determined using
separate assays [9]. The Filipino-specific deletion was ampli-
fied as a 597-bp fragment and the Thai-specific deletion
as a 480-bp fragment. Amplification of the normal alleles
for both deletions was simultaneously amplified in the
same PCR reactions for each deletion. Amplification of
the Mediterranean (--MED) α-thalassemia deletion was not
carried out in this study as this deletion has not been
reported in Malaysia.
In addition, two nondeletional α-thalassemias, Hb
Constant Spring (HbCS) and Hb Quong Sze (HbQS),
reported in Malaysian Malays and Chinese were also deter-
mined using an in-house developed Combine-Amplification
Refractory Mutation System [10]. All PCR products were
electrophoresed on ethidium bromide-stained agarose gels
followed by analysis.
2.2. Molecular Characterization of β-Thalassemia. To deter-
mine the presence of β-thalassemia in the Kadazandusuns,
the Filipino β-thalassemia deletion was screened first as this
mutation was observed in a fairly high frequency in the
indigenous communities in Sabah [6, 11]. The primers, PCR
mixture and PCR condition as described by Waye et al. [12],
were used for the detection of the normal and the Filipino
β-thalassemia deletion-specific sequence in this study.
Twenty-two common and rare β-globin gene mutations
confirmed in Malaysians were determined in the Kadazan-
dusuns using an in-house developed reverse dot blot system.
The 22 mutations characterized are listed in Table 1. The
reverse dot blot used to characterize the β-globin gene
defects was a modification of previously reported proto-
cols [13, 14]. Briefly, specifically designed amino-modified
oligonucleotide probes were applied to negatively-charged
nylon membranes (Biodyne C Membrane, Pall USA). Beta-
globin gene sequences in DNA from the Kadazandusuns
were amplified in a multiplex PCR using DIG-labeled
oligonucleotide primers. Amplified DNA was hybridized
with the membrane strips at 42◦C overnight. Membranes
were washed with 0.5X SSC/0.1% SDS at 42◦C for 30
minutes followed by a second wash with 2X SSC/0.1%
SDS at room temperature, for 15 minutes. Detection was
carried out using anti-Digoxigenin-Alkaline Phosphatase
conjugate (Roche, Germany) followed by colour develop-
ment using Nitro blue tetrazolium chloride/5-Bromo-4-
chloro-3-indolyl phosphate toluidine salt (Roche, Germany).
3. Results and Discussion
Results from the molecular characterization of α- and β-
thalassemia are presented in Table 1. Representative gel
electrophoresis resulting from the Filipino β-thalassemia
deletion in the β-globin gene is shown in Figure 1. The
results from this preliminary study showed that 16/125
(12.8%) of the Kadazandusuns possessed the Filipino β-
thalassemia deletion in the β-globin gene. This indicates a
fairly high presence of β-thalassemia in the Kadazandusuns.
The Filipino β-thalassemia deletion has been reported in
a Filipino family, in two Australian families of Filipino
descent, and in an Indonesian family of Malay descent [15–
17]. The Filipino β-thalassemia deletion was first reported
as a 45-kb deleted sequence in the β-globin gene [16].
However, subsequent investigations of the end points of
the defect confirmed a 118.5-kb deleted sequence [12]. The
deletion was also detected in 6/20 (30%) of mutant alleles
in the Makasarese people from Celebes (East Indonesia)
[18]. In another study of 2954 healthy Filipinos in Taiwan,
the deletion was confirmed in 45.8% of the β-globin gene
mutant alleles [19]. Filipino β-thalassemia deletion is not
present in the Malaysian Malays and Chinese [11], and
appears to be specific only to the indigenous communities
in East Malaysia. Twenty-two other β-globin gene mutations
previously reported in the Malaysian Malay, Chinese, and
Indian racial groups were absent in the Kadazandusuns
studied.
Alpha-thalassemia was also detected in the Kadazan-
dusuns (Figure 2) as the single α-globin gene deletion
(−α3.7) was confirmed in 33.6% (42/125) of the individuals.
Heterozygosity for the deletion (−α3.7/αα) was confirmed in
27.2% (34/125) and homozygosity (−α3.7/ − α3.7) in 6.4%
(8/125) of the Kadazandusuns. The presence of the −α3.7
deletion is high in the Kadazandusuns when compared with
the other racial groups. Previous studies showed that only
10.7% of Malaysian Malays, 10% of Chinese, and 7.4% of
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Table 1: Frequency of α- and β-thalassemia defects in the Kadazandusuns in Sabah.
Deletional α-thalassemia Nondeletional α-thalassemia β-thalassemia
−α3.7 −α4.2 --SEA --FIL --THAI HbCS HbQS Filipino β-thalassemia deletion ∗22 β-mutations
Kadazandusun 42 0 0 0 0 0 0 16 0
n = 125 (%) (33.6%) (12.8%)
∗
The 22 β-thalassemia mutations are CD41/42 (−CTTT), IVS2-654 (C→T), CD26 (GAG→AAG, HBE), IVS1-5 (G→C),−28 (A→G), CD43 (GAG→TAG),
CD27/28 (+C), −29 (A→G), CD71/72 (+A), CD17 (AAG→TAG), CD19 (AAC→AGC), Poly A (AATAAA→AATAGA), −88 (C→T), Initiation codon
(ATG→AGG), CAP (+1) (A→C), CD8/9 (+G), CD16 (−C), CD35 (−C), IVS2-1 (G→A), IVS1-1 (G→A), IVS1-1 (G→T) and CD15 (TGG→TAG).
1 2 3 4 5 6 7 8 9
500 bp
400 bp
300 bp
482 bp
376 bp
Figure 1: Detection of the Filipino β-thalassemia deletion on agarose gel after PCR. Lane 1: 100 bp molecular weight marker; lanes 2-3:
normal controls with a 482-bp band; lanes 4–6: β-thalassemia carriers with the Filipino β-thalassemia deletion indicated by amplification of
a 482 bp normal and a 376-bp deletion specific bands; lanes 7-8: β-thalassemia major with the Filipino β-thalassemia deletion indicated by
amplification of a 376-bp band; lane 9: DNA blank.
Indians possessed this deletion [5]. The single gene −α3.7
deletion has a worldwide distribution [20] and is most
dominant in African, Mediterranean, and Asian populations
[21]. The two nondeletional α-thalassemia studied, HbCS
and HbQS, were absent in the 125 Kadazandusuns samples.
In a previous study in another indigenous group, HbCS
was reportedly present in the Dayaks in Sarawak [22]. The
Filipino (--FIL) and Thai (--THAI) α-thalassemia deletions
were absent in the Kadazandusuns. The Southeast Asian
(--SEA) α-thalassemia deletion reported in Malaysian Chinese
and Malays was also absent in the Kadazandusuns. This
confirms that thalassemia mutations are not only specific
to diﬀerent populations, but can also diﬀer in frequency
between racial and indigenous groups within the same
population.
The indigenous population which comprise 40 ethnic
groups make up about 60% of the estimated 2.6 million
people in Sabah [23]. They speak more than 50 languages
and 80 dialects, and occupy specific geographical areas. The
indigenous population is thus not a homogenous group,
as it diﬀers in physical characteristics, languages, life styles,
social organizations, and religions. The Kadazandusuns are
the most dominant and largest group and are mainly farmers,
but with progress in their social economic status, they are
now also employed as administrators, traders and modern
farmers.
Results from this study indicate that the 118.5-kb Filipino
β-thalassemia deletion and the single α-globin gene deletion
(−α3.7) are highly prevalent in the Kadazandusuns that
inhabit the northern coastal plains and the mountain
interiors of Sabah. Our sampling was from remote villages
in Sonsogan Magandai, Sungai Magandai, Nalapak Pitas, and
Panaitan. These are mainly impoverished villages that some
are inaccessible by proper roads and do not have electricity or
piped water supply. The health of the community is attended
1 2 3 4 5
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Figure 2: Detection of alpha-thalassemia on agarose gel after
multiplex PCR. Lane 1: DNA blank; lane 2: normal controls (αα/αα)
with a 2350 bp LIS1 internal control band and a 1800 bp α2-globin
gene band; lane 3: single α-globin gene deletion carrier (−α3.7/αα)
with an internal control band, a 2022 bp deletion-specific band
and an α2-globin gene band; lane 4: individual homozygous for α-
globin gene deletion (−α3.7/−α3.7) with an internal control band
and a 2022 bp deletion-specific band; lane 5 : 500 bp molecular
weight marker.
to by occasional flying doctors via helicopter service. Serious
health problems are treated at the district hospitals and
the individuals travel 5-6 hours by boats or public vehicles
which cost 50–60 RM for a single journey. However, many
resist seeking medical care as they are unable to pay for
the transportation fare, because most families have unstable
incomes and earn an average of 350 RM per month.
Carriers of α- and β-thalassemia are asymptomatic thus
the aﬀected individuals go through life unaware of their
carrier status. Screening for thalassemia is not carried out on
a routine basis on the Malaysian indigenous population. The
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Kadazandusuns frequently marry within their own group;
thus, the risk of producing β-thalassemia major children
is high since 12.8% of the Kadazandusuns studied possess
Filipino β-thalassemia deletion.
In conclusion, the results from this study will serve as a
baseline for further investigations into the genetic defects,
and to provide better health services for the indigenous
population in Malaysia. The DNA samples collected in this
study were strictly selected from pure Kadazandusuns with
no intermarriages with other ethnic groups for at least three
generations. As the prevalence of both α- and β-thalassemia
is relatively high in the Kadazandusuns, thalassemia screen-
ing should be quickly incorporated as a routine part of
their healthcare system in order to identify asymptomatic
carriers. The challenges to the implementation of more eﬀec-
tive health care will include educating the Kadazandusuns
about thalassemia as an inheritable disorder and, thus, the
possibility of producing severely aﬀected children. Genetic
counseling and prenatal diagnosis have to be made available
to husbands and wives who are carriers so that pregnancies
with β-thalassemia major children are identified early and
informed choices can be made with regards to continuation
or termination of pregnancies. Management of children with
β-thalassemia major should include availability of monthly
blood transfusions and provision of iron chelation therapies
to prevent death due to iron overload. Results and data
derived from this study will be submitted to the Department
for Orang Asli Aﬀairs responsible for medical and health
services for the indigenous populations in Malaysia. Specific
programs relating to thalassemia screening and health care
at the district hospitals for the indigenous populations will
be proposed. Eﬀective changes must be incorporated as the
majority of the indigenous population in Malaysia are still
unaware of their thalassemia status.
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